MS
AGIO icon

Maven Securities’s Agios Pharmaceuticals AGIO Stock Holding History

Maven Securities’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-300,000
Closed -$16M – 595
2020
Q2 		$16M Buy
+300,000
New +$13.9M 1.1% 17
2020
Q1 		– Sell
-225,000
Closed -$10.8M – 304
2019
Q4 		$10.8M Buy
+225,000
New +$8.5M 0.98% 19
2017
Q1 		– Sell
-503
Closed -$21K – 50
2016
Q4 		$21K Buy
+503
New +$26.4K 0.02% 41

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Maven Securities's AGIO Position: Q3 2020 in Review

Maven Securities sold out of Agios Pharmaceuticals (AGIO) in Q3 2020, closing a stake of 300,000 shares — an estimated $16M sold.

Maven Securities first reported a position in AGIO in Q4 2016 and held it in 3 quarters. The position peaked at $16M in Q2 2020. 214 funds tracked by Wall St. Rank hold AGIO as of Q3 2020.

  • Maven Securities reported no remaining Agios Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Maven Securities sold 300,000 Agios Pharmaceuticals shares in Q3 2020, an estimated $16M.
  • Maven Securities first reported a position in Agios Pharmaceuticals in Q4 2016 and held it in 3 quarters.
  • Maven Securities's Agios Pharmaceuticals position peaked at $16M in Q2 2020.
  • 214 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2020.

Based on Maven Securities's 13F filing for Q3 2020, filed 13 Nov 2020.